At GFCT Treatment Support, we are committed to advancing the availability of all prostate cancer treatments, especially focal therapies such as High Intensity Focused Ultrasound (HIFU). These minimally invasive treatments can be life-changing for thousands of men each year, offering effective cancer control with significantly reduced side effects compared to radical surgery or radiotherapy. Through our work, we’re supporting NHS hospitals by helping equip them with the technology need...

Please read this powerful testimonial received this week highlighting the importance of PSA testing: "Good morning, Just thought I would give you some feedback further to my attendance at your Ascot prostate event. Unfortunately I was one of those who did get a red letter after testing, and further scans and biopsies confirmed I have two tumours on my prostate. Both are treatable, and I now await admission to Imperial College, Charing Cross Hospital for treatment. My own...

GP surgeries across South Gloucestershire have launched a powerful new awareness campaign urging men to take just 30 seconds to assess their risk of prostate cancer. The initiative focuses on early detection which is especially important for men over 50, Black men, and those with a family history of the disease. The campaign promotes a quick and simple online risk checker that asks only three questions. It’s being supported by surgeries in the 4PCN and Network 4 groups, including prac...

We received a powerful testimonial this month from someone who had a PSA test with us and later found out they had prostate cancer. Please read: "It happened so quickly. I had a PSA test on Saturday 7th June at Croydon Masonic Halls. I then got an email with my results informing me that my bloods are high, so on Monday, I phoned my doctor and told him the results. Tuesday I had another blood test, Thursday I had an MRI scan, then the following Tuesday 17th I ha...

As well as our PSA testing and awareness initiatives at GFCT, we have recently ventured into supporting the expansion of prostate cancer treatment and diagnosis. Launching as GFCT Focal Therapy Ltd, we recently changed the name to GFCT Treatment Support Ltd to better reflect our broader commitment to supporting all prostate cancer treatment options and helping ease pressure points in the healthcare system. A recent example is our donation of an ultrasound machine to...

Our founder, Graham Fulford MBE, travelled to Scunthorpe General Hospital on Friday 4th July 2025 to present a donated ultrasound machine to the assembled urology team: "It is a privilege to be working with Lead Consultant Urologist, Israr Khan, and his team. It is a real pleasure to be able to make this presentation to help the urology department in it's ongoing battle to diagnose more men with prostate cancer at an earlier stage, thereby improving the patient's chances o...

Got some time for a brew and a chat? Mentell, an incredible charity offering safe, confidential spaces for men to talk, is launching a brand-new Circle in Buxton this month. These free weekly meetings give men the chance to open up, listen, and connect - no pressure, no judgment. To celebrate the launch, Mentell is hosting a relaxed Coffee & Chat event:  Tuesday, 15th July  Grapevine Wellbeing Centre, Buxton  Free drinks & friendly faces Come along to m...

We're delighted to announce that we are sponsoring a charity stand at the BAUN Annual Conference in Edinburgh this November. Urological nurses play a vital and growing role in the prostate cancer diagnosis pathway - taking on advanced procedures such as biopsies, supporting patients throughout their treatment, and driving improvements in care. We’re proud to support them at this important event. The British Association of Urological Nurses (BAUN) is the UK’s leading org...

Veteran broadcaster Dermot Murnaghan, best known for presenting the BBC’s News at Ten, Sky News, and the quiz show Eggheads, has revealed he is living with stage 4 prostate cancer. In a deeply personal message shared on social media, the 67-year-old urged men to get tested, stressing that early detection is vital and that prostate cancer can progress without any noticeable symptoms. “I’m responding positively to their excellent treatment, and feeling well. Needle...

June is Men’s Health Month, bringing global focus to the importance of preventive care, healthy habits, and early detection - especially for prostate cancer, which remains a leading cancer in men. Early diagnosis dramatically boosts survival, with a 5‑year survival rate of about 99% when caught early.  What GFCT Offers in PSA Testing Since 2004, The Graham Fulford Charitable Trust (GFCT) has been bringing early prostate cancer detection directly into communit...